<DOC>
	<DOCNO>NCT03047317</DOCNO>
	<brief_summary>This open label study MABp1 six healthy volunteer . Participants receive single infusion MABp1 7.5 mg/kg IV dose . Participants undergo blood sample pK analysis 15 time point course 2 week ( pre-infusion , 0.5 hr , 1 hr , 1.5 hr , 2 hr , 3 hr , 4 hr , 5 hr , 6 hr , 12 hr , 24 hr , 48 hr , 96 hr , 192 hr , 336 hr ) . In addition pharmacokinetic data , participant monitor development treatment emergent adverse event .</brief_summary>
	<brief_title>A Pharmacokinetic Study MABp1 Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>1 . Age : ≥18 2 . Adequate bone marrow function define : absolute neutrophil count ( neutrophil band ) ≥ 1,500/mm3 ( ≥ 1.5 x 109/L ) platelet count &gt; 150,000/mm3 hemoglobin ≥ 10 g/dL 3 . Adequate renal function , define serum creatinine ≤ 1.5 x lab ULN . 4 . Adequate hepatic function define : total bilirubin ≤ 1.5 time lab ULN . alanine aminotransferase ( ALT ) ≤ 2.0 time lab ULN . 5 . For WOCBP , negative pregnancy test screening . For subject reproductive potential , willingness utilize contraception study least 3 month study completion . Sexually active men must use accepted method contraception study least 3 month study completion . 6 . Signed date Institutional Review Board ( IRB ) approve informed consent protocolspecific screening procedure perform . 1 . Treatment biologicals ( include intravenous immunoglobulin ) investigational agent within last 4 week ( 5 halflives , whichever long ) . 2 . Uncontrolled significant cardiovascular disease , include : A myocardial infarction within past 6 month . Uncontrolled angina within past 3 month . Congestive heart failure within past 3 month , define New York Heart Association ( NYHA ) Classes II high . Uncontrolled hypertension ( blood pressure &gt; 150 mm Hg systolic &gt; 95 mm Hg diastolic ) . 3 . Dementia alter mental status would prohibit understanding rendering informed consent . 4 . Treatment immunosuppressant agent , include corticosteroid cyclosporine within last 4 week . 5 . Serious uncontrolled medical disorder , uncontrolled diabetes , active peptic ulcer disease , recent stroke ( within 3 month ) , ongoing congestive heart failure , condition , opinion investigator , would put subject risk participation protocol . 6 . History severe allergic anaphylactic reaction humanize murine monoclonal antibody . 7 . Infectious disease : CRP &gt; 30 mg/L , infection require treatment antibiotic within 3 week prior Screening , Positive HIV , RPR , Hepatitis C antibody , IGRA 8 . Immunodeficiency history . 9 . Female subject pregnant , plan become pregnant course study , breastfeed . 10 . Major surgery within 28 day prior Day 0 . 11 . WOCBP men whose sexual partner WOCBP unwilling unable use acceptable method contraception least 1 month prior randomization , duration study , least 3 month last dose study medication . 12 . History progressive multifocal leukoencephalopathy demyelinate disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>pharmacokinetics</keyword>
</DOC>